two of the things I really liked about this at the time were :
1) test on Caucasian woman. So clearly planning for products in the USA and elsewhere.
2) the investigation verified clinical benefits to the skin rather than depth of penetration of product. 300% penetration improvement may sound good in marketing and may result in clinical benefits, BUT it is not itself a clinical benefit. The improvement in skin barrier function is an actual clinical benefit that customers should be able to notice.
- Forums
- ASX - By Stock
- WFL
- P&G support OBJ tech 100%
WFL
wellfully limited
Add to My Watchlist
0.00%
!
0.3¢

P&G support OBJ tech 100%, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online